过去一年中添加的文章，按日期排序
Bivalirudin versus unfractionated heparin in patients with myocardial infarction undergoing percutaneous coronary intervention: A systematic review and meta …
285 天前 - Background Bivalirudin is an alternative accepted therapy to unfractionated heparin
for patients with myocardial infarction (MI) undergoing percutaneous coronary intervention
(PCI). We aimed in this meta-analysis to compare bivalirudin versus unfractionated heparin
in patients with MI undergoing PCI. Methods We have screened PubMed/MEDLINE,
Cochrane Library, and ClinicalTrials. gov (inception through January 8th, 2023) for
randomized controlled trials (RCTs) evaluating bivalirudin versus unfractionated heparin in …
for patients with myocardial infarction (MI) undergoing percutaneous coronary intervention
(PCI). We aimed in this meta-analysis to compare bivalirudin versus unfractionated heparin
in patients with MI undergoing PCI. Methods We have screened PubMed/MEDLINE,
Cochrane Library, and ClinicalTrials. gov (inception through January 8th, 2023) for
randomized controlled trials (RCTs) evaluating bivalirudin versus unfractionated heparin in …
以上显示的是最相近的搜索结果。 查看全部搜索结果